Venture Capital Access Online | The eMarketplace for the Venture Capital Industry

 

Bookmark and Share   

Home

Marketplace
Database
Deals
News
Store
Resources
Contact Us

 

 

 

News

 

Venture Capital Database 2014 Now Available

PowerVision Closes $20MM in Its Series D Financing

Company will advance late-stage clinical studies of its revolutionary intraocular lens that enables patient to see near and far ... and all points in between

BELMONT, Calif., January 28, 2014-- PowerVision, Inc., a private company developing an accommodating intraocular lens, today announced the closing of the first tranche of its Series D funding round with participation from existing investors Venrock, Johnson & Johnson Development Corp., Medtronic, Advanced Technology Ventures, Lexington Capital and Frazier Healthcare Ventures. The Company noted that it plans to raise up to an additional $10 million as part of this same financing round. "We plan to invest the funds raised from this financing in advancing the growing body of clinical validation for our revolutionary FluidVision® intraocular lens, including completing the study that should enable us to obtain the CE Mark in Europe next year. We plan to build on the positive results achieved in our pilot study which showed our FluidVision lens restored accommodative functionality in 20 patients who received the lens during cataract surgery," said PowerVision's President and CEO and Co-Founder, Barry Cheskin.

While the market for intraocular lens (IOL) implants continues to grow, exceeding three million procedures annually in the United States alone, patients who receive a conventional IOL all lose their ability to accommodate – to dynamically adjust focus to see at near and far as well as points in between. PowerVision's novel fluid-controlled accommodating intraocular lens technology uses fluid inside its lens in combination with natural muscle forces in the eye to create a shape change in the lens, restoring accommodative ability. The Company has proven in recent clinical trials that it can deliver excellent near, intermediate and distance vision with its new fully injectable accommodating device. This is an unprecedented achievement, making it the first "true" accommodating IOL. PowerVision's products are not yet approved or cleared for sale.

About PowerVision

PowerVision is a private company focused on developing a novel accommodating intraocular lens which it believes will be the first to restore True Accommodation™.

Contact:
Barry Cheskin
President & CEO, Co-Founder
Phone: 650-620-9948 x212
E-mail: bcheskin@powervisionlens.com

Media Contact:
Hollister Hovey
Lazar Partners Ltd.
Phone: 646-871-8482
E-mail: hhovey@lazarpartners.com


News Index

Venture Capital Database

Venture Capital Deals Spreadsheet

 

 NEWS

Latest VC News
VC News Archive
News Search
Venture Capital Deals
RSS News Feed

List Your Firm

Entrepreneurs
Investors
Advisors

Venture Capital Database

VCPro Database
Download Trial
Buy Now

Venture Capital Deals

vcaDeals
Download Sample
Buy Now

VC Tools

VC Pitch
Private Placement Memorandum

Business Plan Tools

Free Business Plan Template
Business Plan Tools

 

 

Copyright © 1998-2014 Access InterComm  All rights reserved. 
Site Map | Privacy Statement | Legal Notice & Disclaimer